NVDA

102.03

-7.67%↓

AVGO.US

154.4

-10.48%↓

ORCL

137.16

-6.03%↓

CRM

254.91

-6.32%↓

CSCO

57.35

-7.28%↓

NVDA

102.03

-7.67%↓

AVGO.US

154.4

-10.48%↓

ORCL

137.16

-6.03%↓

CRM

254.91

-6.32%↓

CSCO

57.35

-7.28%↓

NVDA

102.03

-7.67%↓

AVGO.US

154.4

-10.48%↓

ORCL

137.16

-6.03%↓

CRM

254.91

-6.32%↓

CSCO

57.35

-7.28%↓

NVDA

102.03

-7.67%↓

AVGO.US

154.4

-10.48%↓

ORCL

137.16

-6.03%↓

CRM

254.91

-6.32%↓

CSCO

57.35

-7.28%↓

NVDA

102.03

-7.67%↓

AVGO.US

154.4

-10.48%↓

ORCL

137.16

-6.03%↓

CRM

254.91

-6.32%↓

CSCO

57.35

-7.28%↓

Search

Genpact Ltd

Geschlossen

BrancheTechnologie

49 -3.05

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

47.83

Max

50.38

Schlüsselkennzahlen

By Trading Economics

Einkommen

9.1M

142M

Verkäufe

38M

1.2B

KGV

Branchendurchschnitt

17.677

96.228

EPS

0.91

Dividendenrendite

1.35

Gewinnspanne

11.365

Angestellte

140,000

EBITDA

22M

228M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+15.89% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.35%

2.26%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

348M

8.9B

Vorheriger Eröffnungskurs

52.05

Vorheriger Schlusskurs

49

Nachrichtenstimmung

By Acuity

50%

50%

166 / 412 Ranking in Technology

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

Genpact Ltd Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. März 2025, 06:45 UTC

Ergebnisse

Generali Operating Profit Rises on Higher Premiums

3. Feb. 2025, 07:06 UTC

Akquisitionen, Fusionen, Übernahmen

UniCredit Says It Holds 4.1% Stake in Generali

30. Jan. 2025, 11:40 UTC

Akquisitionen, Fusionen, Übernahmen

Generali Guides for Faster Earnings Growth, Higher Shareholder Returns -- Update

1. Apr. 2025, 13:31 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

European Insurers Will Be Slower Than Banks to Consolidate, Generali Executive Says -- Interview

1. Apr. 2025, 13:31 UTC

Akquisitionen, Fusionen, Übernahmen

Trends in European Insurance Are Fundamentally Positive, Consumer Demand Is Strong, Terzariol Says

1. Apr. 2025, 13:31 UTC

Akquisitionen, Fusionen, Übernahmen

Smaller Insurance Players Might Become M&A Targets if Conditions Become Challenging, Terzariol Says

1. Apr. 2025, 13:30 UTC

Akquisitionen, Fusionen, Übernahmen

Fewer European Insurers Will Be Around in 10, 20 Years, Generali's Terzariol Says

1. Apr. 2025, 13:30 UTC

Akquisitionen, Fusionen, Übernahmen

European Insurers to Consolidate at Gradual Pace, Generali's Insurance Chief Says

1. Apr. 2025, 08:09 UTC

Market Talk

Generali's Board Tussle Is Main Risk for Shares -- Market Talk

1. Apr. 2025, 07:52 UTC

Market Talk
Ergebnisse

European Insurers Liked by North American Investors -- Market Talk

31. März 2025, 08:09 UTC

Market Talk

Mediobanca's List for Generali's Board Likely to Be Supported, Equita Says -- Market Talk

13. März 2025, 08:00 UTC

Market Talk
Ergebnisse

Generali's Dividend Growth Stands Out -- Market Talk

13. März 2025, 07:57 UTC

Market Talk
Ergebnisse

Generali's Results Look Solid -- Market Talk

13. März 2025, 06:07 UTC

Ergebnisse

Generali Backs 2025-27 Targets

13. März 2025, 06:05 UTC

Ergebnisse

Generali End 2024 AUM EUR863B

13. März 2025, 06:04 UTC

Ergebnisse

Analysts Saw Generali 2024 Dividend EUR1.40

13. März 2025, 06:04 UTC

Ergebnisse

Generali Proposes EUR1.43 Dividend Per Share

13. März 2025, 06:04 UTC

Ergebnisse

Generali 2024 New Business Margin 4.60%

13. März 2025, 06:04 UTC

Ergebnisse

Analysts Saw Generali End 2024 Solvency Ratio 211%

13. März 2025, 06:04 UTC

Ergebnisse

Generali End 2024 Solvency Ratio 210%

13. März 2025, 06:04 UTC

Ergebnisse

Analysts Saw Generali 2024 Combined Ratio 94.0%

13. März 2025, 06:04 UTC

Ergebnisse

Generali 2024 Combined Ratio 94.0%

13. März 2025, 06:03 UTC

Ergebnisse

Analysts Saw Generali 2024 Oper Result EUR7.23B

13. März 2025, 06:03 UTC

Ergebnisse

Generali 2024 Oper Pft EUR7.295B

13. März 2025, 06:03 UTC

Ergebnisse

Analysts Saw Generali 2024 Gross Written Premiums EUR94.21B

13. März 2025, 06:03 UTC

Ergebnisse

Generali 2024 Gross Written Premiums EUR95.19B

13. März 2025, 06:03 UTC

Ergebnisse

Analysts Saw Generali 2024 Adj. Net Pft EUR3.76B

13. März 2025, 06:03 UTC

Ergebnisse

Generali 2024 Adj. Net Pft EUR3.77B

13. März 2025, 06:03 UTC

Ergebnisse

Analysts Saw Generali 2024 Net Pft EUR3.825B

13. März 2025, 06:03 UTC

Ergebnisse

Generali 2024 Net Pft EUR3.72B

Peer-Vergleich

Kursveränderung

Genpact Ltd Prognose

Kursziel

By TipRanks

15.89% Vorteil

12-Monats-Prognose

Durchschnitt 58.56 USD  15.89%

Hoch 65 USD

Tief 55 USD

Basierend auf 9 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Genpact Ltd – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

9 ratings

4

Buy

5

Halten

0

Sell

Technischer Score

By Trading Central

N/A / 4.97Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

Weak Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

166 / 412 Ranking in Technologie

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Genpact Ltd

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, and digital commerce; and end-to-end claim lifecycle management, from claims processing and adjudication to claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers industry-specific solutions for trust and safety, advertising sales support, customer and user experience, and customer care support; and direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It also provides digital operation services; data-tech-Al services; finance and accounting services, such as accounts payable, invoice-to-cash, record to report, financial planning and analysis, and enterprise risk and compliance; CFO advisory services; supply chain, and sourcing and procurement services; sales and commercial, and marketing and experience services; and environmental, social and governance services. The company was founded in 1997 and is based in Hamilton, Bermuda.